Cyclic AMP and cyclic GMP phosphodiesterases: Target for drug development.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. 85, doi. 10.1002/ddr.430120203
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 1988 AND VI 12 AND IP 2
Results: 8
1
2
Endothelium-derived relaxing and contracting factors: New concepts and new findings.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. 131, doi. 10.1002/ddr.430120207
- By:
- Publication type:
- Article
3
Second Messengers as targets for novel drug discovery and development.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. 83, doi. 10.1002/ddr.430120202
- By:
- Publication type:
- Article
4
Role of cyclic AMP in regulating cardiac muscle contractility: Novel pharmacological approaches to modulating cyclic AMP degradation by phosphodiesterase.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. 119, doi. 10.1002/ddr.430120206
- By:
- Publication type:
- Article
5
Masthead.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. fmi, doi. 10.1002/ddr.430120201
- Publication type:
- Article
6
Atrial natriuretic factor: Structural requirements of the peptide for receptor binding, biological activity, and cGMP stimulation.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. 109, doi. 10.1002/ddr.430120205
- By:
- Publication type:
- Article
7
Pharmacological modulation of phosphorylation mechanisms in heart and vasculature.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. 93, doi. 10.1002/ddr.430120204
- By:
- Publication type:
- Article
8
Platelet-activating factor-induced cellular and pathophysiological responses in the cardiovascular system.
- Published in:
- Drug Development Research, 1988, v. 12, n. 2, p. 151, doi. 10.1002/ddr.430120208
- By:
- Publication type:
- Article